Hypertensive Emergency vs. Urgency: Definitions, Diagnosis, and Management

Definitions and Clinical Distinction

• Hypertensive emergency is defined as a systolic/diastolic blood pressure ≥ 180/120 mmHg with acute target‑organ damage, requiring immediate treatment and intensive care admission【2】.
• Hypertensive urgency is defined as a systolic/diastolic blood pressure ≥ 180/120 mmHg without acute target‑organ damage, allowing outpatient oral therapy and follow‑up【2】.

Target‑Organ Damage Requiring Emergency Classification

• Acute target‑organ damage includes neurologic (e.g., hypertensive encephalopathy, intracranial hemorrhage, acute ischemic stroke), cardiac (e.g., acute myocardial infarction, unstable angina, acute left‑ventricular failure with pulmonary edema), vascular (aortic dissection or aneurysm), renal (acute kidney injury, thrombotic microangiopathy), ophthalmologic (malignant hypertension findings), and obstetric (severe pre‑eclampsia/eclampsia) manifestations【2】.

Blood‑Pressure Reduction Targets in Specific Emergencies

• In acute hemorrhagic stroke with an initial systolic BP ≥ 220 mmHg, the goal is to lower SBP cautiously to < 180 mmHg【3】.
• In acute ischemic stroke with BP > 220/120 mmHg, reduce mean arterial pressure by ≈ 15 % during the first hour【3】.

Follow‑Up After Hypertensive Urgency

• Arrange an outpatient visit within 2–4 weeks after discharge to reassess blood pressure and therapy【5】.

White‑Coat Hypertension

Definition (ABPM/HBPM Criteria)

• Office blood pressure ≥ 130/80 mmHg and out‑of‑office (home or daytime ambulatory) blood pressure < 130/80 mmHg after at least 3 months of lifestyle modification defines white‑coat hypertension【6】.

Diagnostic Confirmation

• Ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) should be used to confirm the diagnosis and differentiate it from masked hypertension【2】【7】.

Cardiovascular Risk

• White‑coat hypertension carries a cardiovascular disease risk that approximates that of individuals with normal blood pressure【2】.

Equivalent Office and Out‑of‑Office Values (ACC/AHA)

Evidence Strength

• The definitions, target‑organ damage criteria, and BP reduction targets are based on high‑quality guideline recommendations (e.g., ACC/AHA, ESC) and peer‑reviewed evidence (Annals of Internal Medicine 2018; European Heart Journal 2024).
• Follow‑up timing and white‑coat hypertension diagnostic recommendations are supported by moderate‑quality evidence from large cohort studies and guideline consensus (Circulation 2022; Trends in Cardiovascular Medicine 2020).